JP Patent

JP3815496B2 — 酢酸アニリド誘導体を有効成分とする過活動膀胱治療剤

Assigned to Astellas Pharma Inc · Expires 2006-08-30 · 20y expired

What this patent protects

Patent listed against Myrbetriq.

Drugs covered by this patent

Myrbetriq (MIRABEGRON) · Apgdi

Patent Metadata

Patent number: JP3815496B2
Jurisdiction: JP
Classification: —
Expires: 2006-08-30
Drug substance claim: No
Drug product claim: No
Assignee: Astellas Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.